| Name | risperidone |
|---|---|
| Synonyms |
3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one
Risperidone for system suitability (Y0000370) Risperidone(Risperdal) High Quality Risperidone Raw Powder RISPERIDONE 3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-Methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyriMidin-4-one Risperidone( R 64 766,Risperdal) 3-[2-[4-(6-Fluoro-1,2-benzoisoxazole-3-yl)piperidino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidine-4-one Risperidone //BP 3-[-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-α]pyrimidin-4-one, R-64766, Belivon, Risperdal 6-Benzofuranbutanoicacid,α,γ-dioxo-,ethylester 4h-pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one Apexidone Risoeridone 4h-pyrido(1,2-a)pyrimidin-4-one,6,7,8,9-tetrahydro-3-(2-(4-(6-fluoro-1,2-benzi R 64,766,Risperidone 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2,a]pyrimidin-4-one Rispadal 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-Methyl-6,7,8,9 Risperidone, 5-HT2A / D2 antagonist 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one MFCD00274576 3-[-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, R-64766, Belivon, Risperdal Methanol( Test Risperidone, 1.0 mg/mL) 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl) 4-[2-[4-(6-Fluorobenzo[d]isoxazol-3-yl)-1-piperidyl]ethyl]-3-methyl-2,6-diazabicyclo[4.4.0]deca-1,3-dien-5-one 1,2-Benzisoxazole, 4H-pyrido[1,2-a]pyrimidin-4-one deriv Risperdal Consta Risperidone Dopamine, serotonin, adrenergic and histamine rectors antagonist 3-[2-[4-(6-Fluoro-1,2-benzrsoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetmhydro-2-methyl-4H-pyrido[1,2-α]pyrimidin-4-one Kesperidone Spiron Risperidone Product 3-{2-[4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1 Risperdal OD 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[2,1-b]pyrimidin-4-one soxazol-3-yl)-1-piperidinyl)ethyl)-2-methyl Risperidone for system suitability CRS Risperidone solution Risperdal R 64 766,Risperdal BELIVON RisperidoneQ: What is Risperidone Q: What is the CAS Number of Risperidone Q: What is the storage condition of Risperidone Q: What e the applications of Risperidone Risperidone (R1000600)Q: What is Risperidone (R1000600) Q: What is the CAS Number of Risperidone (R1000600) Psychodal R-64766 Risperidone in Methanol 3-{2-[4-(6-Fluor-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-on RISPERIDAL Belivon Risperidal 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl- (9CI) RISPERDAL R 64 766; RISPERDAL Risperidone> Risperidal 3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one Risperidal and Intermediates 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)pipéridin-1-yl]éthyl}-2-méthyl-6,7,8,9-tétrahydro-4H-pyrido[1,2-a]pyrimidin-4-one 3-[-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL]ETHYL-6,7,8,9-TETRAHYDRO-2-METHYL-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-Methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyriMidin-4-one Risperidone CRS |
| Description | Risperidone is a serotonin 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively. |
|---|---|
| Related Catalog | |
| Target |
5-HT2A Receptor:4.8 nM (Ki) dopamine D2 receptor:5.9 nM (Ki) P-Glycoprotein |
| In Vitro | Risperidone is a serotonin 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively. Risperidone dose-dependently inhibited the release of IL-12 in mature DCs, while the production of IL-10 is dose-dependently increased by Risperidone. A high dose of risperidone can induce TNF-α release from mature DCs[3]. |
| In Vivo | In the first experiment, body weight is found to be slightly but significantly lower in the Risperidone-treated rats as a function of age. Similar to the first experiment, age-dependent differences in body weight are also observed between the three treatment groups in the second locomotor experiment. Rats treated with the 3.0 mg/kg dose of Risperidone weigh less than vehicle-treated rats on postnatal days 35, 38, and 41. The third locomotor experiment involves larger, mixed-sex litters in contrast to the smaller, single-sex litters used in the first two experiments. As noted for the first two experiments, rats treated with Risperidone in the third experiment gain less weight in an age-dependent manner[4]. |
| Animal Admin | Rats[4] A total of 211 Long-Evans rats (56 females and 155 males) are used. Within each study, three groups of roughly equal numbers of rats receive injections of 1.0 mg/kg of Risperidone, 3.0 mg/kg of Risperidone, or the vehicle used for the Risperidone solution as a control. In the first experiment, twenty-six male rats (n=9 in the vehicle and 3.0 mg/kg Risperidone groups; n=8 in the 1.0 mg/kg Risperidone group) are tested for locomotor activity for 20 minutes a day beginning at postnatal day 49 and continuing daily until postnatal day 53. A second experiment determined if the locomotor effects of early-life Risperidone treatment persisted well into adulthood. A third experiment ascertains the effects of sex on the locomotor effects of early-life Risperidone seen in young adult rats. In this experiment, sixty male (n=20 per treatment group) and 56 female (n=19 rats in the vehicle and 3.0 mg/kg dose group, n=18 in the 1.0 mg/kg dose group) rats are treated. A fourth experiment assessed reversal learning during adulthood in rats administered earlylife risperidone. Forty-two male rats (n=14 per treatment group) are treated[4]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 572.4±60.0 °C at 760 mmHg |
| Melting Point | 170°C |
| Molecular Formula | C23H27FN4O2 |
| Molecular Weight | 410.484 |
| Flash Point | 300.0±32.9 °C |
| Exact Mass | 410.211792 |
| PSA | 64.16000 |
| LogP | 2.88 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.677 |
| Storage condition | Room temp |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H301 + H311 + H331-H370 |
| Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| Hazard Codes | T: Toxic; |
| Risk Phrases | R25 |
| Safety Phrases | S28-S36-S45 |
| RIDADR | 3249 |
| RTECS | UV1164800 |
| Packaging Group | II |
| Hazard Class | 6.1(a) |
| HS Code | 2934999090 |
| Precursor 9 | |
|---|---|
| DownStream 3 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |